Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease in China: A Multicenter, Single-Arm, Prospective, Observational Real-World Study

NCT06780683 is registered in ClinicalTrials.gov with Xiang Gao as lead sponsor.

NCT NCT06780683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06780683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease in China: A Multicenter, Single-Arm, Prospective, Observational Real-World Study
Lead sponsor
Xiang Gao
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2024
Completion date
December 31, 2028
Enrollment
174 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, inflammatory bowel disease, ulcerative colitis